JPRN-UMIN000040885已完成未知
Phase II Exploratory Study of EVA-001 for Osteoarthritis of the Knee - Phase II Exploratory Study of EVA-001 for Osteoarthritis of the Knee
EVASTEM Co., Ltd.0 个研究点目标入组 50 人开始时间: 2020年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet any of the following criteria shall be excluded 1)no remaining lateral cartilage due to progressive osteoarthritis of the knee 2) autoimmune diseases or a history of such diseases 3)an infection or suspected infection requiring parenteral antibiotics 4)serious cardiovascular disease (myocardial infarction, congestive heart failure, uncontrolled hypertension, or other serious cardiac disease) or a history of such disease 5)gout or suspected gout 6)blood clotting abnormalities 7)serious renal function abnormalities 8)serious liver damage 9)serious medical conditions 10)malignancy or suspected malignancy 11)who are pregnant or potentially pregnant 12)who are currently breastfeeding 13)mental disorders or a history of mental disorders 14)who are habitual drinkers and are dependent or suspected of being alcoholic 15)who are nicotine dependent or suspected to be so 16)chronic inflammatory joint diseases 17)who have received immunosuppressive drugs such as cyclosporine A or azathioprine within the past 6 weeks 18)ligament fiber damage of Grade II or greater 19)paralysis due to nerve or muscle disease on the side of the knee joint cartilage damage or defect 20)a history of serious hypersensitivity to bovine-derived or porcine derived ingredients of this product 21)a history of severe hypersensitivity or anaphylactic shock to gentamicin 22)a history of severe hypersensitivity or anaphylactic shock to metal allergy 23)a history of severe hypersensitivity or anaphylaxis to sodium hyaluronate or products containing hyaluronic acid 24)a history of blood transfusion or transplantation 25)who have participated in another clinical trial within the past 3 months 26)who have been at rest for a long period of time within the past 3 months 27)a history of contraindications to MRI or contrast media 28)meniscus locking symptoms 29) Other patients who are determined to be unsuitable by the investigator or sub-investigator
研究者
相似试验
暂停
2 期
Phase II Exploratory Study of EVA-001 for Osteoarthritis of the KneeOstheoarthritis of the kneeJPRN-jRCT2033210138Yamamoto Masao50
招募中
2 期
Phase II Exploratory Study of EVA-001 for Osteoarthritis of the Kneeosteoarthritis of the kneeJPRN-jRCT1080225305EVASTEM Co., Ltd.50
招募中
3 期
Phase-III Comparative Study of EVA-001 for Osteoarthritis of the KneeOsteoarthritis of the kneeJPRN-jRCT2033210646ee Antonio130
已完成
1 期
A Phase 1b, Single-centre, Open-label Study to Evaluate Food Effect and the Drug-Drug Interaction of Omeprazole, Itraconazole and Rifampin on Tinlarebant in Healthy Adult SubjectsGeographic AtrophyEye - Diseases / disorders of the eyeACTRN12624000031561RBP4 Pty Ltd49
进行中（未招募）
不适用
Open-Label, Multicenter Phase II Study For the Evaluation of Dasatinib (Sprycel™) Following Induction and Consolidation Therapy as well as in Maintenance Therapy in Patients With Newly Diagnosed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)ewly diagnosed core binding factor acute myeloid leukemia.EUCTR2008-008238-35-DEniversitätsklinikum Ulm214